dr. aggarwal on the future of adt for patients with prostate cancer
Published 6 years ago • 228 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:00
dr. aggarwal on androgen deprivation therapy for prostate cancer
-
1:32
dr. agarwal on treatment for newly diagnosed prostate cancer
-
1:26
dr. agarwal on potential agents for metastatic hormone-sensitive prostate cancer
-
1:44
dr. agarwal on the stampede and latitude trials for prostate cancer
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
1:37
dr. agarwal on drug development in metastatic castration-sensitive prostate cancer
-
6:14
intermittent versus continuous androgen-deprivation therapy in prostate cancer
-
8:00
hope for cancer patients: liver transplant for colorectal liver metastasis - transmet trial
-
1:05
dr. agarwal on androgen receptor inhibitors for prostate cancer
-
5:59
challenges associated with adt for prostate cancer
-
1:02
dr. agarwal on the safety profile of enzalutamide/talazoparib in mcrpc
-
12:11
triggers to initiate androgen-deprivation therapy (adt) in prostate cancer
-
2:13
dr. agarwal on the cosmic-021 trial design in castration-resistant prostate cancer
-
27:50
new concepts in adt
-
1:30
ai biomarker predicts benefit of long-term adt in prostate cancer
-
4:05
adt and its consequences in the treatment of prostate cancer
-
6:24
age, exercise, and adt for prostate cancer
-
1:24
dr. tward on abbreviated course adt for prostate cancer
-
6:40
considerations for initiating adt in prostate cancer